BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25415868)

  • 1. Ultrasonography-guided radiofrequency ablation of malignant musculoskeletal soft-tissue tumors using the "moving-shot" technique at a single-institution experience.
    Kim SJ; Chung HW; Baek JH; Lee JS; Lee SH; Lee MH; Shin MJ
    Ultrasound Q; 2014 Dec; 30(4):295-300. PubMed ID: 25415868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Guided Moving Shot Radiofrequency Ablation of Benign Soft Tissue Neoplasm.
    Lin WC; Tai YF; Chen MH; Luo SD; Huang F; Chen WC; Chiang PL; Chen HL; Chen MH; Baek JH
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441036
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of intraperitoneal saline infusion for percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Park SY; Tak WY; Jeon SW; Cho CM; Kweon YO; Kim SK; Choi YH
    Eur J Radiol; 2010 Jun; 74(3):536-40. PubMed ID: 19398290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-guided radiofrequency ablation of osteoid osteoma and osteoblastoma: clinical success and long-term follow up in 77 patients.
    Rehnitz C; Sprengel SD; Lehner B; Ludwig K; Omlor G; Merle C; Kauczor HU; Ewerbeck V; Weber MA
    Eur J Radiol; 2012 Nov; 81(11):3426-34. PubMed ID: 22770580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
    Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
    Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral and soft-tissue tumors: radiofrequency and alcohol ablation for pain relief--initial experience.
    Nair RT; vanSonnenberg E; Shankar S; Morrison PR; Gill RR; Tuncali K; Silverman SG
    Radiology; 2008 Sep; 248(3):1067-76. PubMed ID: 18710995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
    Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-guided percutaneous radiofrequency ablation in osteoid osteoma: re-assessments of results with optimized technique and possible pain patterns in mid-term follow-up.
    Omlor G; Merle C; Lehner B; Ewerbeck V; Rehnitz C; Weber MA; Ludwig K
    Rofo; 2012 Apr; 184(4):333-9. PubMed ID: 22271256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.
    Chiou YY; Hwang JI; Chou YH; Wang HK; Chiang JH; Chang CY
    Kaohsiung J Med Sci; 2005 Jul; 21(7):304-9. PubMed ID: 16089307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided radiofrequency ablation (RFA) of unresectable hepatic tumors using a triple-spiral-shaped electrode needle: initial experience in 34 patients.
    Thanos L; Poulou LS; Ziakas PD; Kelekis AD; Pomoni M; Kelekis DA
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):107-12. PubMed ID: 19626363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors.
    Lackey L; Peterson C; Barr RG
    Ultrasound Q; 2012 Dec; 28(4):269-74. PubMed ID: 23149509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
    del Cura JL; Zabala R; Iriarte JI; Unda M
    Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.
    Hegg RM; Schmit GD; Kurup AN; Weisbrod AJ; Boorjian SA; Atwell TD
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):508-12. PubMed ID: 23934115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer].
    Han Y; Hao YZ; Cai JQ; Yang M; Liu S; He LF; Yu L; Chen MH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules.
    Cesareo R; Pasqualini V; Simeoni C; Sacchi M; Saralli E; Campagna G; Cianni R
    J Clin Endocrinol Metab; 2015 Feb; 100(2):460-6. PubMed ID: 25387256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.